Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

This study has been terminated.

(Terminated early dt acquisition of Sponsor and change in corporate priorities)

Sponsor:

Information provided by (Responsible Party):

Aires Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier:

NCT01725269

First received: November 8, 2012

Last updated: April 7, 2014

Last verified: April 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2014
Primary Completion Date:	April 2014 (Final data collection date for primary outcome measure)